PTC Therapeutics: 3Q Earnings Snapshot
SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Monday reported a loss of $51 million in its third quarter.
On a per-share basis, the South Plainfield, New Jersey-based company said it had a loss of $1.06. Losses, adjusted for asset impairment costs, came to 94 cents per share.
The biopharmaceutical company posted revenue of $53.6 million in the period.
PTC Therapeutics shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.